STOCKHOLM, Feb. 21, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today, that an article comparing US and German dermatologists improved biopsy decisions following the addition of...
Read More Details
Finally We wish PressBee provided you with enough information of ( New study shows significant improved clinical accuracy with Nevisense for both US and German dermatologists )
Also on site :